UniQure readout tests durability of benefits, an AI effort to manage heart failure, and more biotech news from The Readout ...

A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall ...

Before the end of September, UniQure is expected to report four-year results from the closely tracked clinical trial of its ...

A Roivant lung disease drug has succeeded in a mid-stage study. But the drug’s origins are another fascinating aspect to the ...

Feds invest in AI for heart failure, vaccines and this year's midterms, and more health news from Morning Rounds ...

The two measles-related deaths in Pennsylvania last month involved infants, and the virus itself caused one of the deaths, a ...

A U.K. commission has unveiled its recommendations for how the country should regulate artificial intelligence in medicine.

ARPA-H, the government agency that funds cutting edge health research, plans to commit $62.7 million to develop artificial ...

Nothing in the recent reporting about John Fetterman is medically surprising,” write Michael P.H. Stanley and Isaiah Kletenik.

Rural health care providers, which have struggled for years, are facing nearly $1 trillion in Medicaid cuts over the coming ...

GOP candidates in Iowa and Florida are embracing vaccine skepticism, while Democrats in Michigan and South Carolina are ready for a fight.

WASHINGTON — The Trump administration permanently filled four key leadership roles at the Food and Drug Administration on ...